In regulatory news:

U.S. Health and Human Services (HHS) has issued final rules for a number of efforts it made to curb the nation’s opioid abuse problem. The actions included expanding access to buprenorphine (a medication to treat opioid use disorder), a proposal to eliminate any potential financial incentive for doctors to prescribe opioids based on patient experience survey questions, and a requirement for Indian Health Service prescribers and pharmacists to check state Prescription Drug Monitoring Program (PDMP) databases before prescribing or dispensing opioids for pain. In addition, the department is launching more than a dozen new scientific studies on opioid misuse and pain treatment and soliciting feedback to improve and expand prescriber education and training programs. The actions announced build on the HHS Opioid Initiative, which was launched in March 2015.

Read more here. Download the Initiative document here: HHS Opioid Initiative 2016

Leave a Comment

Your email address will not be published. Required fields are marked *